Showing results (351-360 of 390) with videos related to

Sort By:
Pageof 39
Journal of Medicinal Chemistry|May 16, 2014
Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding regionSameer P Kawatkar, Thomas A Keating, Nelson B Olivier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2013
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancerR J Kelly, A Thomas, A Rajan, et al.
Leukemia Research|August 24, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute myelogenous leukemia in 1st remissionR P Gale, R E Park, R W Dubois, et al.
Bioconjugate Chemistry|May 14, 2016
Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid ConjugatesJose F Ponte, Xiuxia Sun, Nicholas C Yoder, et al.
Leukemia Research|October 23, 1998
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in adults with acute lymphoblastic leukemia in first remissionR P Gale, R E Park, R W Dubois, et al.
Leukemia Research|September 4, 1999
Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phaseR P Gale, R E Park, R W Dubois, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2026
Medicinal cannabis plant extract (NTI164) modifies epigenetic, ribosomal, and immune pathways in paediatric acute-onset neuropsychiatric syndromeBrooke A Keating, Velda X Han, Hiroya Nishida, et al.
Ebiomedicine|May 20, 2024
Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndromeErica Tsang, Velda X Han, Chloe Flutter, et al.
ACS Medicinal Chemistry Letters|August 16, 2019
Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody-Drug Conjugates (ADCs)Katie E Archer, Emily E Reid, Manami Shizuka, et al.
Molecular Pharmaceutics|July 10, 2019
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine ConjugationNicholas C Yoder, Chen Bai, Daniel Tavares, et al.
Pageof 39